Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2024 > The role of angiogenic factor in the development of endothelial dysfunction in women of reproductive age with abnormal uterine bleeding and obesity

The role of angiogenic factor in the development of endothelial dysfunction in women of reproductive age with abnormal uterine bleeding and obesity

Marina B. Khamoshina , Gulrukhsor Kh. Tolibova , Tatyana G. Tral , Yulia S. Artemenko

For citation:


  • Abstract
  • About the Author
  • References

Abstract

The steady increase in the number of patients with abnormal uterine bleeding (AUB) has a negative impact on a woman's reproductive health. Obesity is defined as one of the risk factors for AUB and its role in the development of AUB-M and AUB-O has been studied to date. However, our earlier analysis of the results of histological examination of endometrial biopsies showed that in obese women with AUB, the desquamation phase (AUB-E) is significantly more common in the endometrium than in normal-weight women. One of the possible pathogenetic mechanisms may be abnormal endometrial vascularization due to systemic proinflammatory status and local tissue hypoxia.
Aim. To identify the features of the expression of endothelial markers CD34+ and eNOS in endometrial biopsies of patients with AUB and obesity and their role in the pathogenesis of endometrial dysfunction.
Materials and methods. A prospective randomized cohort study included 40 patients of reproductive age with AUB-E. Depending on the presence of obesity, women were stratified into 2 groups: 20 patients with AUB-E and obesity (group 1) and 20 normal-weight patients with AUB-E (group 2). 10 healthy women of reproductive age were included as a control group. All patients underwent endometrial biopsy followed by histological examination according to the standard procedure. At the second stage, an immunohistochemical study of CD34+ and eNOS angiogenesis markers was performed using monoclonal mouse antibodies in standard dilution. The IBM SPSS Statistics v.26 program (IBM Corporation, USA) was used for statistical data analysis.
Results. CD34+ expression in patients with AUB and obesity was significantly higher than in normal-weight patients with AUB and healthy women (2,5±0,2, respectively; 95% CI 2,1–2,8 vs. 1,8±0,2; 95% CI 1,5–2,2 and 0,5±0,1; 95% CI 0,4–0,6; p1-2=0,03; p1-3<0,001; p2-3<0,001), as well as eNOS expression (respectively 8,7±0,6; 95% CI 7,3–10,0 vs. 4,0±0,5; 95% CI 3–5 and 1,3±0,2; 95% CI 0,9–1,7; p1-2<0,001; p1-3<0,001; 
p2-3<0,001).
Conclusion. Patients with AUB-E and obesity are characterized by increased expression of CD34+ and eNOS in endometrial tissue, which indicates pathological activation of neoangigenesis. Perhaps one of the mechanisms of pathogenesis is the formation of a proinflammatory profile against the background of obesity, which contributes to the pathological hypervascularization of the endometrium. Effective weight loss measures can probably reduce the incidence and recurrence of AUB-E.
Keywords: abnormal uterine bleeding, obesity, endometrial dysfunction, CD34+, eNOS.

About the Author

Marina B. Khamoshina 1 , Gulrukhsor Kh. Tolibova 2 , Tatyana G. Tral 3 , Yulia S. Artemenko 1

1 People’s Friendship University of Russia (RUDN University), Moscow, Russia;

2 Ott Research Institute of Obstetrics, Gynecology and Reproductology, Saint Petersburg, Russia;

3 Ott Research Institute of Obstetrics, Gynecology and Reproductology, Saint Petersburg, Russia; Mechnikov North-Western State Medical University, Saint Petersburg, Russia

References

1. Critchley HOD, Babayev E, Bulun SE et al. Menstruation: science and society. Am J Obstet Gynecol. 2020;223(5):624-64. DOI: 10.1016/j. ajog.2020.06.004
2. Munro MG, Critchley HOD, Fraser IS; FIGO Menstrual Disorders Committee. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393-408. DOI: 10.1002/ijgo.12666
3. Аномальные маточные кровотечения. Клинические рекомендации. Минздрав России. М., 2021. Дата обращения: 12.03.2024. URL: https://cr.minzdrav.gov.ru/recomend/645_1 Abnormal uterine bleeding. Clinical recommendations Ministry of Health of the Russian Federation. Moscow, 2021. URL: https://cr.minzdrav.gov.ru/recomend/645_1. Date of application: 12.03.2024 (in Russian).
4. Matteson KA, Raker CA, Clark MA, Frick KD. Abnormal uterine bleeding, health status, and usual source of medical care: analyses using the Medical Expenditures Panel Survey. J Womens Health (Larchmt). 2013;22(11):959-65. DOI: 10.1089/jwh.2013.4288
5. Munro MG, Critchley HO, Broder MS, Fraser IS. FIGO classification system (PALM- COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113:3-13. DOI: 10.1016/j.ijgo.2010.11.011
6. Jain V, Chodankar RR, Maybin JA, Critchley HOD. Uterine bleeding: how understanding endometrial physiology underpins menstrual health. Nat Rev Endocrinol. 2022;18(5):290-308. DOI: 10.1038/ s41574-021-00629-4
7. Armstrong GM, Maybin JA, Murray AA. Endometrial apoptosis and neutrophil infiltration during menstruation exhibits spatial and temporal dynamics that are recapitulated in a mouse model. Sci Rep. 2017;7:17416. DOI: 10.1038/s41598-017-17565-x
8. Critchley HOD, Maybin JA, Armstrong GM, Williams ARW. Physiology of the endometrium and regulation of menstruation. Physiol Rev. 2020; 100: 1149-79. DOI: 10.1152/physrev.00031.2019
9. Biswas Shivhare S, Bulmer JN, Innes BA et al. Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components. Hum Reprod. 2018;33(3):399-410. DOI: 10.1093/humrep/dex378
10. Maybin JA, Murray AA, Saunders PTK et al. Hypoxia and hypoxia inducible factor-1α are required for normal endometrial repair during menstruation. Nat Commun. 2018;9(1):295. DOI: 10.1038/s41467-017-02375-6
11. Vannuccini S, Jain V, Critchley H, Petraglia F. From menarche to menopause, heavy menstrual bleeding is the underrated compass in reproductive health. Fertil Steril. 2022;118(4):625-36. DOI: 10.1016/ j.fertnstert.2022.07.021
12. Yetkin-Arik B, Kastelein AW, Klaassen I et al. Angiogenesis in gynecological cancers and the options for anti-angiogenesis therapy. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188446. DOI: 10.1016/j.bbcan. 2020.188446
13. Middelkoop MA, Don EE, Hehenkamp WJK et al. Angiogenesis in abnormal uterine bleeding: a narrative review. Hum Reprod Update. 2023;29(4):457-85. DOI: 10.1093/humupd/dmad004
14. Harmsen MJ, Wong CFC, Mijatovic V et al. Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review. Hum Reprod Update. 2019;25(5):647-71. DOI: 10.1093/humupd/dmz024
15. Ожирение и избыточный вес. Информационный бюллетень ВОЗ. Веб-сайт: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (дата обращения 14.03.2024)
16. Unamuno X, Gómez-Ambrosi J, Rodríguez A et al. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest. 2018;48(9):e12997. DOI: 10.1111/eci.12997
17. Ng M, Fleming T, Robinson M et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766-81. DOI: 10.1016/S0140-6736(14)60460-8
18. Артеменко Ю.С., Хамошина М.Б., Петренко Н.В., Демина О.А. Патоморфологические особенности эндометрия при аномальных маточных кровотечениях у пациенток репродуктивного возраста с ожирением. Акушерство и гинекология: новости, мнения, обучение. 2023;11(Спецвыпуск):36-41. DOI: 10.33029/2303-9698-2023-11-suppl-36-41 Artemenko Yu.S., Khamoshina M.B., Petrenko N.V., Demina О.А. Pathomorphological features of endometrium in abnormal uterine bleeding in obese patients of reproductive age. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie = Obstetrics and Gynecology: News, Opinions, Training. 2023;11(Supplement): 36-41. DOI: 10.33029/ 2303-9698-2023-11-suppl-36-41 (in Russian). 
19. Murray PJ, Allen JE, Biswas SK et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14-20. DOI: 10.1016/j.immuni.2014.06.008
20. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017;127(1):1-4. DOI: 10.1172/ JCI92035
21. Nteeba J, Ortinau LC, Perfield JW 2nd, Keating AF. Diet-induced obesity alters immune cell infiltration and expression of inflammatory cytokine genes in mouse ovarian and peri-ovarian adipose depot tissues. Mol Reprod Dev. 2013;80(11):948-58. DOI: 10.1002/mrd.22231
22. Reavey JJ, Walker C, Murray AA et al. Obesity is associated with heavy menstruation that may be due to delayed endometrial repair. J Endocrinol. 2021;249(2):71-82. DOI: 10.1530/JOE-20-0446
23. Holdsworth-Carson SJ, Chung J, Sloggett C et al. Obesity does not alter endometrial gene expression in women with endometriosis. Reprod Biomed Online. 2020;41(1):113-8. DOI:10.1016/j.rbmo.2020.03.015
24. Schoots MH, Gordijn SJ, Scherjon SA et al. Oxidative stress in placental pathology. Placenta. 2018;69:153-61. DOI: 10.1016/j.placenta. 2018.03.003
25. Траль Т.Г., Толибова Г.Х. Экспрессия эндотелиального фактора CD34+ в гравидарном эндометрии при репродуктивных потерях после эко и привычном невынашивании беременности. Современные проблемы науки и образования. 2022;(6). DOI: 10.17513/spno. 32173 Tral TG, Tolibova GKh. Expression of endothelial factor cd34+ in the gravid endometrium in women with reproductive losses after ivf and recurrent miscarriage. Sovremennie problemi nauki i obrazovania = Modern problems of science and education. 2022;(6). DOI: 10.17513/spno.32173 (in Rissian).
26. Martínez-Martínez E, Souza-Neto FV, Jiménez-González S, Cachofeiro V. Oxidative Stress and Vascular Damage in the Context of Obesity: The Hidden Guest. Antioxidants (Basel). 2021;10(3):406. DOI: 0.3390/antiox10030406
27. Goossens GH, Blaak EE. Adipose tissue dysfunction and impaired metabolic health in human obesity: a matter of oxygen? Front Endocrinol (Lausanne). 2015;(6):55. DOI: 10.3389/fendo.2015.00055

For citation:Khamoshina M.B., Tolibova G.H., Tral T.G., Artemenko Y.S. The role of angiogenic factor in the development of endothelial dysfunction in women of reproductive age with abnormal uterine bleeding and obesity. Clinical review for general practice. 2024; 5 (3):47–53. (In Russ.). DOI: 10.47407/kr2023.5.3.00373


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru